Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Preston

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Pediatric Infectious Disease|January 1, 1986
Microbiological aspects of erythromycinD A Preston
Clinical Therapeutics|January 1, 1993
Global surveillance of bacterial susceptibility to cefaclor: 1988-1990D A Preston
Journal of Clinical Microbiology|June 26, 1999
Interpretation of pneumococcal susceptibility tests with cefaclorD A Preston
Reviews of Infectious Diseases|November 1, 1982
Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteriaD A Preston
Infection|January 1, 1979
Summary of laboratory studies on the antibacterial activity of cefaclorD A Preston
Postgraduate Medical Journal|January 1, 1979
Summary of laboratory studies on the antibacterial activity of cefaclorD A Preston
The New Zealand Medical Journal|June 8, 1977
The health expenditure problem in New ZealandD A Preston
Journal of Chemotherapy (Florence, Italy)|July 21, 1998
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globeD A Preston, M Turik
Journal of Clinical Microbiology|January 1, 1985
Effect of refrigerated storage on cefaclor in Mueller-Hinton agarA M Surprenant, D A Preston
Antimicrobial Agents and Chemotherapy|March 1, 1972
Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibioticsW E Wick, D A Preston
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Pediatric Infectious Disease|January 1, 1986
Microbiological aspects of erythromycinD A Preston
Clinical Therapeutics|January 1, 1993
Global surveillance of bacterial susceptibility to cefaclor: 1988-1990D A Preston
Journal of Clinical Microbiology|June 26, 1999
Interpretation of pneumococcal susceptibility tests with cefaclorD A Preston
Reviews of Infectious Diseases|November 1, 1982
Differences among moxalactam, cefoperazone, and cefotaxime in activity against multiple-antibiotic-resistant gram-negative bacteriaD A Preston
Infection|January 1, 1979
Summary of laboratory studies on the antibacterial activity of cefaclorD A Preston
Postgraduate Medical Journal|January 1, 1979
Summary of laboratory studies on the antibacterial activity of cefaclorD A Preston
The New Zealand Medical Journal|June 8, 1977
The health expenditure problem in New ZealandD A Preston
Journal of Chemotherapy (Florence, Italy)|July 21, 1998
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globeD A Preston, M Turik
Journal of Clinical Microbiology|January 1, 1985
Effect of refrigerated storage on cefaclor in Mueller-Hinton agarA M Surprenant, D A Preston
Antimicrobial Agents and Chemotherapy|March 1, 1972
Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibioticsW E Wick, D A Preston
Pageof 5